Detalhe da pesquisa
1.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
2.
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.
Oncologist
; 25(5): e816-e832, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219909
3.
Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).
Strahlenther Onkol
; 195(6): 544-557, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859254
4.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514803
5.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
6.
Histopathological changes resulting from selective internal radiotherapy (SIRT).
J Surg Oncol
; 117(5): 1084-1091, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448307
7.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Br J Haematol
; 179(4): 586-597, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961309
8.
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Blood
; 126(1): 42-9, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918346
9.
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
Br J Cancer
; 115(12): 1520-1529, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802454
10.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Lancet
; 385(9976): 1418-27, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539730
11.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662018
12.
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
Ann Hematol
; 95(12): 1931-1942, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696203
13.
Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety.
J Surg Oncol
; 112(4): 436-42, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256832
14.
Prioritization and resource allocation in the context of the COVID-19 pandemic. Recommendations for colorectal and pancreatic cancer in Germany.
Oncol Res Treat
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484712
15.
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Lancet Oncol
; 13(12): 1250-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23168367
16.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427146
17.
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.
Leuk Lymphoma
; 63(8): 1871-1878, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848865
18.
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
Front Immunol
; 13: 1008438, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275695
19.
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.
J Clin Invest
; 132(24)2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326824
20.
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Lancet Haematol
; 8(4): e267-e277, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667420